Axim Biotechnologies Correlations
| AXIM Stock | USD 0 0.0004 11.76% |
The current 90-days correlation between Axim Biotechnologies and biOasis Technologies is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axim Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axim Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Axim Biotechnologies Correlation With Market
Average diversification
The correlation between Axim Biotechnologies and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and DJI in the same portfolio, assuming nothing else is changed.
Axim |
The ability to find closely correlated positions to Axim Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axim Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axim Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axim Biotechnologies to buy it.
Moving together with Axim Pink Sheet
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Axim Pink Sheet performing well and Axim Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Axim Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CMVLF | 1.83 | (0.88) | 0.00 | (0.85) | 0.00 | 0.00 | 40.94 | |||
| BITRF | 10.07 | 3.71 | 0.00 | 0.58 | 0.00 | 2.04 | 400.54 | |||
| RGIN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BIOAF | 12.16 | 5.07 | 0.00 | (0.94) | 0.00 | 0.00 | 300.00 | |||
| AKESF | 2.21 | 0.27 | 0.06 | (1.23) | 2.85 | 7.72 | 29.15 | |||
| ADYX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ASCLF | 6.39 | 3.43 | 0.00 | 12.84 | 0.00 | 8.33 | 170.83 | |||
| WSNAF | 47.38 | 19.36 | 0.56 | (9.34) | 23.68 | 120.00 | 681.82 | |||
| BVAXF | 4.82 | (0.19) | 0.00 | 2.42 | 0.00 | 10.40 | 32.45 | |||
| GHRS | 5.01 | 1.25 | 0.29 | (0.91) | 4.01 | 11.89 | 80.36 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Axim Biotechnologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Axim Biotechnologies Corporate Management
| Joseph MD | Chief Board | Profile | |
| Catalina JD | I Biotech | Profile | |
| Dr MBA | I Biotech | Profile | |
| John II | CEO Pres | Profile | |
| Robert Malasek | CFO Sec | Profile | |
| Jeffrey Busby | Sr Devel | Profile | |
| Alim SeitNebi | I Biotech | Profile |